Drug Development Research
Country
United States
Northern America
Subject Area and Category
Pharmacology, Toxicology and Pharmaceutics
└
Drug Discovery
Q2
Publisher
SJR 2025
0.765
Q2
SJR Score
H-Index
76
Citations / Doc (2yr)
4.42
Total Docs. (latest)
165
Total Citations (3yr)
1,911
Publication type
Journals
ISSN
02724391, 10982299
Coverage
1981-2026
Journal Rank
#7,352
Subject Categories
Drug Discovery
Q2
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 165 |
| Total Docs. (3 years) | 424 |
| Total Refs. | 11,397 |
| Total Citations (3 years) | 1,911 |
| Citable Docs. (3 years) | 413 |
| Citations / Doc. (2 years) | 4.42 |
| Ref. / Doc. | 69.07 |
| % Female | 44.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Drug Development Research?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Drug Development Research has an SJR of 0.765 and is ranked Q2.
What is the SJR and quartile of Drug Development Research?
Drug Development Research has an SJR (SCImago Journal Rank) of 0.765 and its best quartile is Q2.
What is the H-index of Drug Development Research?
The H-index of Drug Development Research is 76, meaning 76 of its articles have each been cited at least 76 times.
Is Drug Development Research indexed in Scopus?
Yes. Drug Development Research is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.